Disease · MONDO_0043373
Trials16
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 16 of 16
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00097448 | Sudden Deafness Treatment Trial | Phase 3 | 255 | 2013-04-04 | Sudden Deafness | METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISONE | Its record names the disease | ClinicalTrials.gov |
| NCT02809118 | Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment | Phase 3 | 56 | 2020-08-07 | Hearing Loss, Idiopathic Sudden Sensorineural | BRIMAPITIDE, C-TERMINAL ACID | Its record names the disease | ClinicalTrials.gov |
| NCT02026479 | Sudden Hearing Loss Multi-center Clinical Trial | Not applicable | 300 | Full-frequency Sudden Hearing Loss | DEXAMETHASONE PHOSPHORIC ACID | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT02561091 | AM-111 in the Treatment of Acute Inner Ear Hearing Loss | Phase 3 | 256 | Hearing Loss | BRIMAPITIDE, C-TERMINAL ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT07134075 | Intracochlear Injection of Glucocorticoid | Phase 2 | 150 | Sudden Sensorineural Hearing Loss (SSNHL) | DEXAMETHASONE, TRIAMCINOLONE ACETONIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT07113158 | Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss | Phase 3 | 142 | Sudden Sensorineural Hearing Loss | ASPIRIN, FOLIC ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT05403229 | The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss | Phase 2 | 140 | Sudden Deafness, Sudden Sensorineural Hearing Loss | TOPIRAMATE | Its record names the disease | ClinicalTrials.gov | |
| NCT07540728 | Trans-round Window Membrane Intracochlear Steroid | Phase 2 | 108 | Sudden Hearing Loss | DEXAMETHASONE, TRIAMCINOLONE ACETONIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT05623384 | Effect of Ultrasound-guided Stellate Ganglion Block Combined With Facial Nerve and Glossopharyngeal Nerve Block on the Treatment of Sudden Deafness | Not applicable | 90 | Sudden Deafness | MECOBALAMIN | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT06467526 | Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss | Phase 2 | 80 | Sudden Hearing Loss | HYDROXYCHLOROQUINE, PREDNISOLONE | Its record names the disease | ClinicalTrials.gov | |
| NCT03974867 | Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids | Not applicable | 72 | Vestibular Vertigo, Sudden Hearing Loss | METHYLPREDNISOLONE, PREDNISONE | Its record names the disease | ClinicalTrials.gov | |
| NCT04129983 | Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation | Not applicable | 60 | Hearing Loss, Sudden, Prednisone Acetate, Hyperbaric Oxygen, Somatic Stimulus | PREDNISONE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT05849519 | Small Sample，Unicentric，Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss | Early phase 1 | 36 | Sudden Sensorineural Hearing Loss | NADIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT01621256 | Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss | Phase 1/2 | 31 | Hearing Loss, Deafness, Hearing Loss, Sensorineural, Hearing Disorders, Ear Diseases | ANCROD | Its record names the disease | ClinicalTrials.gov | |
| NCT04129697 | Intratympanic Steroids for Sudden Hearing Loss | Not applicable | 30 | Dexamethasone or Methylprednisolone; Sudden Hearing Loss; Intratympanic Steroid | DEXAMETHASONE, METHYLPREDNISOLONE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT06707389 | Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness | Early phase 1 | 30 | Sudden Deafness, Sensorineural Hearing Loss | METHYLPREDNISOLONE | Open Targets' reading of its record | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0043373/trials